[1]
Zawam, H., Ibrahim, N.E. , Salama, R., Samir, M., Abdelfattah, W., El Demerdash, D.M., Sabry, D., Tabak, S.A. and Khairy, R.A. 2021. Impact of Genetic Polymorphism of Myeloid Differentiation Primary Response Gene 88, Enhancer of Zeste Homolog 2, and B-cell Lymphoma 2 like 11 in Patients with Diffuse Large B Cell Lymphoma Treated with Rituximab, Cyclophosphamide, Doxorubicin, Vincristin. Open Access Macedonian Journal of Medical Sciences. 9, A (Feb. 2021), 98–105. DOI:https://doi.org/10.3889/oamjms.2021.5697.